Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy.
about
Stem cell treatment for acute myocardial infarctionEndothelial Progenitor Cells for Diagnosis and Prognosis in Cardiovascular DiseaseAdult stem cells as a tool for kidney regenerationAre Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and PerspectivesAdipose tissue-derived stem cells as a therapeutic tool for cardiovascular diseaseApplication and Progress of Combined Mesenchymal Stem Cell Transplantation in the Treatment of Ischemic CardiomyopathyBone marrow-derived cell transplantation therapy for myocardial infarction: lessons learned and future questionsImmunobiology of fibrin-based engineered heart tissueGeneration of Functional Cardiomyocytes from Efficiently Generated Human iPSCs and a Novel Method of Measuring ContractilityRegenerating functional heart tissue for myocardial repairHuman iPS Cell-Derived Cardiac Tissue Sheets: a Platform for Cardiac RegenerationThe winding road to regenerating the human heartDetection of intramyocardially injected DiR-labeled mesenchymal stem cells by optical and optoacoustic tomographyEndothelial cell-derived pentraxin 3 limits the vasoreparative therapeutic potential of circulating angiogenic cellsTracking of stem cells in vivo for cardiovascular applications.The dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patientsEndothelial progenitor cells: therapeutic perspective for ischemic stroke.Engineered 3D bioimplants using elastomeric scaffold, self-assembling peptide hydrogel, and adipose tissue-derived progenitor cells for cardiac regeneration.Homing of Cultured Endothelial Progenitor Cells and Their Effect on Traumatic Brain Injury in Rat ModelTransendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.Cell and gene therapy for severe heart failure patients: the time and place for Pim-1 kinase.A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy.Stem cell-derived endothelial cells for cardiovascular disease: a therapeutic perspective.Fused X-ray and MR imaging guidance of intrapericardial delivery of microencapsulated human mesenchymal stem cells in immunocompetent swineImpact of intracoronary reinfusion of bone marrow-derived mononuclear progenitor cells on cardiopulmonary exercise capacity in patients with chronic postinfarction heart failure.Bone mesenchymal stem cells contributed to the neointimal formation after arterial injuryUltrasound-mediated microbubble destruction enhances the therapeutic effect of intracoronary transplantation of bone marrow stem cells on myocardial infarction.Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients.Progenitor/stem cell transplantation for repair of myocardial infarction: Hype or hope?Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells.Long-Term Outcome of Combined (Percutaneous Intramyocardial and Intracoronary) Application of Autologous Bone Marrow Mononuclear Cells Post Myocardial Infarction: The 5-Year MYSTAR StudyCell-based therapy for prevention and reversal of myocardial remodelingSafety and feasibility of cell-based therapy of autologous bone marrow-derived mononuclear cells in plate-stabilized proximal humeral fractures in humans.Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.Comparison of three different types of scaffolds preseeded with human bone marrow mononuclear cells on the bone healing in a femoral critical size defect model of the athymic rat.Ultrastructural evidence of exosome secretion by progenitor cells in adult mouse myocardium and adult human cardiospheres.Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trialHistopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model.Progenitor Cell Therapy to Treat Acute Myocardial Infarction: The Promise of High-Dose Autologous CD34(+) Bone Marrow Mononuclear Cells.Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction.
P2860
Q24186920-EEC26809-7170-43B7-AD7E-12DA86E928BAQ26770056-0BAEBCBA-D376-412A-9B94-9F43FB89D947Q26770750-0359DBC2-FFC1-4F39-BEF0-5C13881A2287Q26778217-81FC19EE-EF8A-464F-81E9-28B323BEDAA2Q26795749-18B4ADFA-9507-4F98-BF9F-B0137503C41AQ26796004-CD5E41D0-F131-46DC-B8E0-2DA7AB6B85C5Q27026874-8D880406-B348-49F5-BA1C-BF734B85CFDEQ27301288-35698CEC-E3A6-426D-B6A8-269F8CEB303FQ27301480-A3B0CAB6-0C14-4559-8C48-04C1C31091CDQ27687840-85340F13-A907-406D-8C68-C63EDF4F6843Q28077395-B0844328-FE51-476E-802A-94D2DC5D7819Q28081476-CFC77D6A-F161-418F-AB0B-5B86C2E4F4F2Q30355871-80CC5CCB-A8C7-4EDF-814B-15D1B19A9F7CQ30367803-C86DFB77-F6DA-4B19-9C7B-C3FE9225F0F1Q30443013-20470F7A-6367-4615-B3CE-E88D59BAE10CQ33662677-06DD430F-EDA9-4B70-AF6B-484DBF3DF14CQ33705402-5214F251-CCEF-40EC-8B2D-97759A60E2FCQ33758005-A80A1FFC-466D-4825-9914-698707A5A604Q33829809-710436F3-5852-4AE0-9C16-FFF06884E4D7Q33950809-180D7A68-3E45-4EE0-8DA6-58EF13F81C66Q34075071-C0D9707B-2161-44F6-A3AE-97657B6000DFQ34149206-B69FF87F-CFA1-4A6B-A96B-2C6581107F26Q34306425-8AC0C8E9-BDB2-42C0-96B6-1E9F4C20F134Q34343125-FA3CD766-38EC-4927-9749-34579094E048Q34683330-B38063AD-99E5-4504-98B2-89AE1D3CD7ADQ35070477-72FA6C76-4E62-4C32-9F94-284B0F1C5959Q35405864-A0AFCD4E-33E7-46E7-9F90-439EB780B968Q35509900-144EA185-D96D-4CBD-9968-452526938BF6Q36108608-36B06C81-8787-4956-BDEE-562CFCD22AF6Q36135052-10148562-8599-4C63-8DE9-1C0F1E2825C9Q36169198-C266DA95-41B3-4D51-A407-0267900F152DQ36176132-C1D6939D-E7C7-44F3-9951-A28EB68BE5EFQ36193483-D67A1292-27DE-4183-BFE5-82205C98DB60Q36326838-ECD968E6-2832-4B06-A710-1865CD5BA904Q36382712-28EAE08D-1B56-4840-9B20-60F1248A546AQ36438947-28494000-ECBB-442E-BFE2-60931904D5ACQ36603453-D06C5805-ACFA-4686-9002-C78749FFE936Q36615851-CDF0211F-2A7C-48F8-8904-1548E0FF3515Q36848798-F2054806-E9D4-41E6-A60E-38C59C1F2229Q36881332-108E2C4C-55A5-4F61-B410-75E9E385BBC8
P2860
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Transplantation of progenitor ...... long-term safety and efficacy.
@ast
Transplantation of progenitor ...... long-term safety and efficacy.
@en
type
label
Transplantation of progenitor ...... long-term safety and efficacy.
@ast
Transplantation of progenitor ...... long-term safety and efficacy.
@en
prefLabel
Transplantation of progenitor ...... long-term safety and efficacy.
@ast
Transplantation of progenitor ...... long-term safety and efficacy.
@en
P2093
P2860
P50
P1476
Transplantation of progenitor ...... long-term safety and efficacy.
@en
P2093
Florian H Seeger
Hans Martin
Iris Burck
Jörg Honold
Ralf Lehmann
Ulrich Fischer-Rasokat
Volker Schächinger
P2860
P2888
P304
P356
10.1007/S00392-011-0327-Y
P577
2011-06-03T00:00:00Z